Merck KGaA (OTCMKTS:MKKGY) Short Interest Down 80.2% in August

Merck KGaA (OTCMKTS:MKKGY) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 1,771 shares, a decrease of 80.2% from the August 15th total of 8,948 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 98,007 shares, the days-to-cover ratio is currently 0.0 days.

Wall Street Analysts Forecast Growth

MKKGY has been the subject of a number of research reports. HSBC raised shares of Merck KGaA to a “hold” rating in a research report on Monday, July 6th. UBS Group downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 20th. Jefferies Financial Group initiated coverage on Merck KGaA in a research report on Tuesday, May 26th. They set a “hold” rating on the stock. Finally, Zacks Research downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Merck KGaA has a consensus rating of “Hold”.

Merck KGaA Stock Performance

Shares of OTCMKTS:MKKGY traded down $0.03 during trading on Friday, hitting $30.46. 51,395 shares of the company were exchanged, compared to its average volume of 45,804. Merck KGaA has a 52-week low of $23.73 and a 52-week high of $34.19. The stock has a 50 day moving average of $32.15 and a 200 day moving average of $29.58. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.51 and a quick ratio of 1.00. The company has a market cap of $19.68 billion, a PE ratio of 15.70, a P/E/G ratio of 2.86 and a beta of 0.96.

Merck KGaA Company Profile

Merck KGaA is a Germany-based science and technology company headquartered in Darmstadt. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical businesses. Merck KGaA operates independently from the U.S.-based Merck & Co, Inc, which uses the name MSD in markets outside the United States and Canada.

The company operates through three primary business sectors: Life Science, Healthcare and Electronics. Its Life Science business supplies laboratory products, research tools, bioprocessing equipment and services used by academic institutions, pharmaceutical manufacturers and other industrial customers.